Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

How ALS is diagnosed, and what else it could be

Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

The most important thing a diagnostic workup for ALS does is not confirm ALS. It is to find the conditions that imitate it and can be treated.

Some of those are genuinely treatable, and missing one is the error that matters most.

Related pages: ALS (amyotrophic lateral sclerosis)

The bottom line

What we know
  • There is no single blood test or scan that diagnoses ALS.
  • Diagnosis rests on a clinical pattern plus electrical testing of nerve and muscle.
  • Imaging and blood tests are done mainly to exclude other conditions.
  • Several treatable conditions can resemble ALS early on.
What is still open
  • How much the delay to diagnosis could be reduced in practice.
  • Whether blood biomarkers such as neurofilament light chain will become diagnostic rather than supportive.

The story, step by step

  1. 1. The clinical picture ()
  2. 2. The tests ()
  3. 3. The mimics ()
  4. 4. The criteria ()
  5. 5. The delay ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 5

What the neurologist is looking for

Review of many studies

What happens

The diagnosis begins and ends with examination.

What the research shows

  • Evidence of lower motor neuron damage: weakness, wasting, fasciculations.
  • Evidence of upper motor neuron damage: brisk reflexes, spasticity, abnormal reflexes.
  • Both, in the same region, and in more than one body region.
  • Progression over time, documented across visits. This is essential and is one reason diagnosis is rarely made at a single appointment.
  • Absence of findings that point elsewhere, such as sensory loss, bladder involvement or eye movement problems.

Why it matters

Progression over time is part of the diagnostic criteria, which is why a second appointment weeks or months later is standard rather than a delay.

What's still uncertain

  • Early in the disease the pattern may be incomplete, and a diagnosis of possible or probable ALS may be made first.

Read more

Next: The tests

Part 2 of 5

What each one is for

Review of many studies

What happens

The investigations have distinct purposes, and most are about exclusion.

What the research shows

  • Electromyography, EMG: a needle records electrical activity in muscle, detecting denervation and the enlarged motor units of reinnervation, including in muscles that still feel normal.
  • Nerve conduction studies: measure how well nerves carry signals, and are mainly used to exclude neuropathies that mimic ALS.
  • MRI of the brain and spine: to exclude spinal cord compression, multiple sclerosis, tumours and structural causes.
  • Blood tests: thyroid and parathyroid function, vitamin B12, creatine kinase, inflammatory and immune markers, and tests for infections such as HIV and Lyme disease where relevant.
  • Genetic testing: offered where there is a family history, and increasingly more broadly, since it affects treatment eligibility.
  • Lumbar puncture in some cases, to exclude inflammatory and infectious causes.

Why it matters

EMG is the test that extends the examination into muscles that look normal, which is how the required pattern is often established.

What's still uncertain

  • EMG is uncomfortable and operator-dependent, and may need repeating if early results are inconclusive.

Read more

Next: The mimics

Part 3 of 5

What must be excluded

Review of many studies

What happens

This is the part of the workup that can change everything, and some of these are treatable.

What the research shows

  • Multifocal motor neuropathy with conduction block: causes progressive painless asymmetric weakness without upper motor neuron signs, and responds to immunoglobulin treatment. Missing it means missing a treatable disease.
  • Cervical spondylotic myelopathy: compression of the spinal cord in the neck can produce wasting in the hands with brisk reflexes in the legs, closely mimicking ALS. It is treated surgically.
  • Myasthenia gravis: causes fatigable weakness including of speech and swallowing, and is treatable.
  • Kennedy's disease, spinal and bulbar muscular atrophy: an inherited condition that resembles ALS but progresses far more slowly and is confirmed genetically.
  • Inclusion body myositis, thyroid and parathyroid disorders, vitamin B12 deficiency, Lyme disease and HIV-associated syndromes.

Why it matters

This list is why a neurologist and a full workup matter, rather than a single scan or a label applied quickly.

What's still uncertain

  • Distinguishing some mimics requires repeated testing over time.

Read more

Next: The criteria

Part 4 of 5

Formalizing the pattern

Review of many studies

What happens

Diagnostic criteria exist to make the process consistent, particularly for research.

What the research shows

  • The revised El Escorial criteria classified cases as possible, probable or definite ALS according to how many body regions showed both types of signs.
  • The Awaji criteria allowed EMG findings to count as equivalent to clinical lower motor neuron signs, which improved earlier diagnosis.
  • The Gold Coast criteria, introduced more recently, simplified this further and are more sensitive early in the disease.
  • These categories exist mainly for trial eligibility and research consistency. A category of possible ALS does not mean the diagnosis is in doubt in the way the word suggests.
  • Neurofilament light chain, a marker of nerve damage measurable in blood and spinal fluid, is increasingly used as supportive evidence and to track treatment effects.

Why it matters

If you see the phrase possible ALS on a letter, it is a technical classification rather than a statement about how certain the neurologist is.

What's still uncertain

  • No criteria set is perfectly sensitive early in the disease.

Read more

Next: The delay

Part 5 of 5

Why it takes so long, and what helps

Review of many studies

What happens

The average time from first symptom to diagnosis is around a year, and that is a recognized problem.

What the research shows

  • Early symptoms are vague and common, and are reasonably attributed to more likely causes first.
  • The disease must progress for the pattern to become clear, and that takes time by definition.
  • People are often referred to orthopaedics, ENT or other specialties first, which is understandable and adds months.
  • A second opinion at a specialist ALS centre is reasonable and routine, not a sign of mistrust. Multidisciplinary ALS clinics also improve care and survival independently of any drug.
  • If ALS is confirmed, referral to such a clinic is the single most useful next step.

Why it matters

Asking for referral to a specialist ALS clinic is the most useful thing to request at the point of diagnosis.

What's still uncertain

  • Access to specialist clinics varies widely by region.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.